Oracle Life Sciences InForm 7.0.1.0/7.0.1.1 IDM Authentication Remote Code Execution

Summaryinfo

A vulnerability was found in Oracle Life Sciences InForm 7.0.1.0/7.0.1.1. It has been rated as critical. Impacted is an unknown function of the component IDM Authentication. The manipulation leads to Remote Code Execution. This vulnerability is referenced as CVE-2026-34323. Remote exploitation of the attack is possible. No exploit is available. Upgrading the affected component is advised.

Detailsinfo

A vulnerability, which was classified as critical, has been found in Oracle Life Sciences InForm 7.0.1.0/7.0.1.1. This issue affects an unknown function of the component IDM Authentication. The manipulation with an unknown input leads to a remote code execution vulnerability. Impacted is confidentiality, integrity, and availability. The summary by CVE is:

Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: IDM Authentication). Supported versions that are affected are 7.0.1.0 and 7.0.1.1. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data and unauthorized ability to cause a partial denial of service (partial DOS) of Oracle Life Sciences InForm. CVSS 3.1 Base Score 6.3 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L).

It is possible to read the advisory at oracle.com. The identification of this vulnerability is CVE-2026-34323 since 03/26/2026. The exploitation is known to be easy. The attack may be initiated remotely. No form of authentication is needed for a successful exploitation. The technical details are unknown and an exploit is not publicly available. The pricing for an exploit might be around USD $0-$5k at the moment (estimation calculated on 04/22/2026).

Upgrading eliminates this vulnerability.

Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.

Productinfo

Vendor

• Oracle

Name

• Life Sciences InForm

Version

• 7.0.1.0
• 7.0.1.1

License

• commercial

Website

• Vendor: https://www.oracle.com

CPE 2.3info

• 🔒
• 🔒

CPE 2.2info

• 🔒
• 🔒

CVSSv4info

CVSSv3info

CVSSv2info

Exploitinginfo

Threat Intelligenceinfo

Countermeasuresinfo

Timelineinfo

Sourcesinfo

Entryinfo

Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.

Discussion